Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 AUD | -3.77% | -20.31% | -10.53% |
May. 28 | Opthea Limited Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD | CI |
May. 28 | Opthea Completes Enrollments in COAST, ShORe Trials | MT |
Sales 2024 * | 922K 613K | Sales 2025 * | 17.45M 11.61M | Capitalization | 338M 225M |
---|---|---|---|---|---|
Net income 2024 * | -278M -185M | Net income 2025 * | -224M -149M | EV / Sales 2024 * | 533 x |
Net Debt 2024 * | 154M 102M | Net Debt 2025 * | 212M 141M | EV / Sales 2025 * | 31.5 x |
P/E ratio 2024 * |
-1.11
x | P/E ratio 2025 * |
-1.58
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 94.31% |
1 day | -3.77% | ||
1 week | -20.31% | ||
1 month | -17.74% | ||
3 months | -20.31% | ||
6 months | -2.86% | ||
Current year | -10.53% |
Managers | Title | Age | Since |
---|---|---|---|
Frédéric Guerard
CEO | Chief Executive Officer | 51 | 23-10-26 |
Megan Baldwin
FOU | Founder | 49 | 07-12-31 |
Peter F. Lang
DFI | Director of Finance/CFO | 52 | 23-10-26 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Levin
CHM | Chairman | 70 | 20-10-04 |
Quinton Oswald
BRD | Director/Board Member | - | 22-04-20 |
Lawrence Gozlan
BRD | Director/Board Member | 45 | 20-07-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 0.51 | -3.77% | 711,727 |
24-05-30 | 0.53 | -3.64% | 1,969,502 |
24-05-29 | 0.55 | -6.78% | 1,223,767 |
24-05-28 | 0.59 | -4.07% | 754,519 |
24-05-27 | 0.615 | -3.91% | 361,079 |
Delayed Quote Australian S.E., May 31, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.53% | 224M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- OPT Stock